id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-P-1863-0004,FDA,FDA-2022-P-1863,Final Response Letter from FDA CDER to University of Colorado School of Medicine,Other,Partial Petition Approval and Denial,2024-12-27T05:00:00Z,2024,12,2024-12-27T05:00:00Z,,2024-12-27T20:13:14Z,,0,0,090000648688ca83
FDA-2022-P-1863-0003,FDA,FDA-2022-P-1863,Interim response from FDA CDER to University of Colorado School of Medicine,Other,Response(s),2023-02-03T05:00:00Z,2023,2,2023-02-03T05:00:00Z,,2023-02-03T17:08:20Z,,0,0,0900006485630b5f
FDA-2022-P-1863-0002,FDA,FDA-2022-P-1863,Acknowledgment Letter from FDA DMS to Colorado Society of Addiction Medicine,Other,Acknowledgement Letter/Receipt,2022-08-10T04:00:00Z,2022,8,2022-08-10T04:00:00Z,,2022-08-10T12:57:37Z,,0,0,090000648522a735
FDA-2022-P-1863-0001,FDA,FDA-2022-P-1863,Citizen Petition from Colorado Society of Addiction Medicine,Other,Citizen Petition,2022-08-10T04:00:00Z,2022,8,2022-08-10T04:00:00Z,,2024-12-26T18:39:18Z,,0,0,090000648522a72f